Loading...
Pro: Tolvaptan delays the progression of autosomal dominant polycystic kidney disease
No treatment until now has directly targeted the mechanisms responsible for the development and growth of cysts in autosomal dominant polycystic kidney disease (ADPKD). Strong rationale and preclinical studies using in vitro and in vivo models justified the launching of two large phase 3 clinical tr...
Na minha lista:
| Udgivet i: | Nephrol Dial Transplant |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6657439/ https://ncbi.nlm.nih.gov/pubmed/30312438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy297 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|